Business / Finance

RSS

UCSF Medical Center acquires BSD-2000 Hyperthermia System

BSD Medical Corporation announced today that the prestigious University of California San Francisco Medical Center (UCSF Medical Center) has purchased a BSD-2000 Hyperthermia System (BSD-2000).

19 Jul 2012

Mindray acquires orthopedics business of Dragonbio

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today the completion of its acquisition of Wuhan Dragonbio Surgical Implant's orthopedics business pursuant to the terms of the definitive agreement entered into on June 6, 2012.

From Mindray 18 Jul 2012

Unisys becomes AOptix strategic alliance partner

AOptix Technologies, Inc., a leading provider of advanced optical technologies and products, today announced that Unisys, a worldwide information technology company, has become an AOptix strategic alliance partner.

17 Jul 2012

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson today announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011. Operational results increased 3.5% and the negative impact of currency was 4.2%.

17 Jul 2012

Life Technologies acquires Navigenics

Life Technologies Corporation today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.

17 Jul 2012

Thermo Fisher Scientific signs definitive agreement to acquire One Lambda

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire One Lambda, the leader in transplant diagnostics, for $925 million in cash, subject to a post-closing adjustment.

From Thermo Fisher Scientific Inc. 17 Jul 2012

Biomet fourth quarter net sales increase 3% to $739.5 million

Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2012. The final results for the three and twelve months ended May 31, 2012 will be made available to the public with the filing of Biomet's Form 10-K for fiscal year 2012 and will include the finalization of a non-cash goodwill and intangible asset impairment charge as further described below and certain income tax accounts.

17 Jul 2012

Hospedia acquires Extramed

Healthcare providers globally can now benefit from millions of dollars in potential savings thanks to UK-based Hospedia's acquisition of patient flow and bed management provider Extramed today.

16 Jul 2012

Sectra acquires product rights for Intulo from Krucom

The IT and medical technology company Sectra has acquired the product rights for Intulo, a system that monitors radiation doses, from the Swedish medical IT company Krucom AB.

16 Jul 2012

Xylem acquires MJK

Xylem Inc., a leading global water technology company focused on addressing the world's most challenging water issues, announced today that it has acquired MJK Automation A/S, a privately owned company headquartered in Naerum, Denmark for approximately $12.3 million (DKK 75 million).

16 Jul 2012

Global Fund hosts first business forum in Bangkok to encourage private-sector support

"The Global Fund to Fight Aids, Tuberculosis and Malaria on Wednesday opened its first business forum in Bangkok to encourage more private-sector support in combating the three epidemics," Thailand's The Nation reports.

14 Jul 2012

SunLink closes $9,975,000 loan for Trace Regional Hospital in Houston

SunLink Health Systems, Inc. today announced that it closed a $9,975,000 loan for its Trace Regional Hospital in Houston, MS. Approximately $1,475,000 of the loan proceeds will be used to make improvements to the hospital and its medical office building, as well as for working capital and costs.

12 Jul 2012

Bristol-Myers Squibb commences cash tender offer to purchase all shares of Amylin common stock

Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.

10 Jul 2012

Quintiles introduces Allume to help biopharmaceutical companies

Quintiles today introduced Allume, a comprehensive go-to-market service to help biopharmaceutical companies efficiently launch new products and shorten timelines to peak sales, while retaining strategic and corporate control of their assets.

10 Jul 2012

PsiOxus closes Series B round of equity financing

PsiOxus Therapeutics, Ltd. announced that it has closed a Series B round of equity financing totaling £22 million ($34 million).

9 Jul 2012

Genkyotex closes CHF25M Series C extension

Genkyotex, the leading developer of NOX inhibitors to treat oxygen-radical mediated diseases, announced today the closing of a CHF25 million (USD26 million) extension to its Series C financing. Investors in the Series C round, including Eclosion, Edmond de Rothschild Investment Partners, Vesalius Biocapital Partners, MP Healthcare Venture, all participated in the financing extension.

9 Jul 2012

CHS commences cash tender offer and consent solicitation for 8⅞% Senior Notes due 2015

Community Health Systems, Inc. today announced that its wholly-owned subsidiary, CHS/Community Health Systems, Inc., has commenced a cash tender offer for any and all of its approximately $934 million outstanding principal amount of 8⅞% Senior Notes due 2015.

4 Jul 2012

SunLink sells Memorial Hospital and Convalescent Center in Adel

SunLink Health Systems, Inc. today announced that it completed the sale of its Memorial Hospital of Adel and Memorial Convalescent Center to The Hospital Authority of Tift County, Georgia for approximately $8,350,000.

3 Jul 2012

PharMerica to purchase $25 million of common stock

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.

3 Jul 2012

Pernix to acquire Great Southern

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced that it has entered into a definitive agreement to acquire Great Southern Laboratories, a privately-held pharmaceutical contract manufacturing company located in Houston, Texas.

3 Jul 2012